PCOS. pregnancy complications. Prof. Bart CJM Fauser. Dept. Reproductive Medicine and Gynecology. University Medical Center, Utrecht, The Netherlands

Size: px
Start display at page:

Download "PCOS. pregnancy complications. Prof. Bart CJM Fauser. Dept. Reproductive Medicine and Gynecology. University Medical Center, Utrecht, The Netherlands"

Transcription

1 PCOS pregnancy complications Prof. Bart CJM Fauser Dept. Reproductive Medicine and Gynecology University Medical Center, Utrecht, The Netherlands

2 Disclosure of interest, Fauser Professor of Reproductive Medicine Chair, WHO steering committee infertility guidelines Board member Dutch Medical Research Counsel Chief Editor Reproductive Biomedicine Online COGI chair Executive boards international organisations Consultant various pharmaceutical companies Visiting professor at different international institutions

3 PCOS, a condition requiring live long attention Reproductive disorders Metabolic disease 15 yrs 60 yrs Future health child Future health women

4 PCOS, Cross generations Fertility intervention Periconception Intervention? Pregnancy Intervention? Childhood Intervention? PCOS Pregnancy Birth Childhood NATURE NURTURE Adult Health

5 Periconceptional medicine PCOS: Genetic predisposition Environmental factors 5

6 HR 2012 Cumulative pregnancy rates resulting in singleton live birth

7 Odds ratio 95% CI No Studies Gestational diabetes Pregnancy induced hypertension Hum Reprod Upd 2006 Sample size > Preeclampsia Birth weight (WMD) NICU admission Perinatal death

8 OR gestational diabetes in PCOS HRU 2006

9 pregnancy outcomes in PCOS - summary Outcome Metaanalysis1 === Boomsma, HRU 06 Metaanalysis2 === Kjerulff, AJOG 11 Population based cohort === Roos, BMJ 11 Gest. diabetes Pre-eclampsia Preterm birth

10 189 pregnant women with PCOS Factors in the model: Relatives with type 2 DM Fasting glucose Fasting insulin AD SHBG

11 Pregnancy complications in PCOS - especially in the hyperandrogenic fenotype 188 PCOS and controls

12 Neonatal complications in PCOS children - especially in the hyperandrogenic fenotype

13 2016 Uncomplicated PCOS/Uncomplicated PCOS/GDM PCOS/pre-eclampsia F&S 2016

14 JCEM 2009

15 PCOS children (3-4 years) PCOS children Reference group Adjusted mean difference P value adjusted Anthropometry (n= 42) (n=168) (95% CI) age Blood pressure Systolic blood pressure (mmhg) 93.4 ± ± (-3.0 to 2.6) 0.89 Diastolic blood pressure (mmhg) 47.7 ± ± (-5.2 to -0.7) 0.01 Mean arterial pressure (mmhg) 62.9 ± ± (-4.3 to 0.1) 0.06 Pulse pressure (mmhg) 45.7 ± ± (0.5 to 5.0) 0.02 Arterial stiffness Pulse wave velocity aorta (m/s) 5.8 ± ± (-0.2 to 0.5) 0.49 Pulse pressure aorta (mmhg) 38.0 ± ± (-0.2 to 3.9) 0.08 Systolic blood pressure on aorta (mmhg) 85.2 ± ± (-5.3 to 1.2) 0.21 Echocardiography Left ventricle internal diameter end-diastolic (mm) (PLAX) 33.7 ± ± (0.4 to 2.5) 0.01 Z-score left ventricle internal diameter end-diastolic * a 0.4 ± ± (0.2 to 0.9) Left ventricle internal diameter end-systolic (mm) (PLAX) 22.3 ± ± (0.2 to 1.9) 0.02 Tissue doppler imaging septum systole (cm/s) 6.5 ± ± (-0.7 to -0.1) 0.01 De Wilde, Submitted

16 PCOS children (6-8 years) PCOS group Reference group Adjusted mean difference *a Anthropometry (n=32) (n=130) (95% CI) P value adjusted for age & weight Endocrinology Glucose (mmol/l) 4.7 ± ± (-0.1 to 0.4) 0.07 Insulin (miu/l) 4.4 ± ± (-2.2 to 0.8) 0.34 Cholesterol (mmol/l) 4.9 ± ± (0.3 to 1.2) Triglycerides (mmol/l) 0.7 ± ± (0.1 to 0.3) HDL-cholesterol (mmol/l) 1.5 ± ± (-0.1 to 0.2) 0.39 LDL-cholesterol (mmol/l) 3.1 ± ± (0.1 to 0.9) 0.02 CRP (mg/l) 1.6 ± ± (-3.1 to 0.8) 0.25 Carotid IMT Carotid int media thickness (µm) ± ± (6.4 to 43.0) 0.01 De Wilde, Submitted

17 Summary of Case control studies; Children of women with PCOS Design Country, no childr PCOS diagnosis Offsprin g (n) Offspring age Outcomes studied Results Kent 2008 Recabarren 2008 Infants Recabarren 2008 Childhood Sir-Petermann 2007 Prepuberty Sir-Petermann 2007 Puberty Sir-Petermann 2009 Tanner I Sir-Petermann 2009 Tanner II Sir-Petermann 2009 Tanner III Sir-Petermann 2009 Tanner IV Sir-Petermann 2009 Tanner V Legro, 2017 Case Control USA NIH 1990 :7 :10 P=17, : 11 C=16 : ± ± ± ±1.3 BMI, fasting glucose, insulin, lipids, gonadotropins, sex steroids CC Chile NIH 1990 : ( ) BMI, fasting : ( ) P=80, C=56 : ( ) : ( ) Glucose, insulin, HOMA-IR, riglycerides,ldl SHBG, adiponectin, leptin, CRP CC Chile NIH 1990 : ( ) BMI, fasting : ( ) P=75, C=49 : (101-6) : (10-17) glucose, insulin, lipids gonadotropins, sex steroids, SHBG, adiponectin CC Chile NIH 1990 : ±0.9 BMI, fasting : ±1.2 CC matched P=99, C=84 USA P=76 C=80 NIH 1990 : ±1.0 : ±0.7 : ±1.5 : ±1.0 : ±1.5 : ±1.4 : ±1.7 : ±1.1 only 4-17 yrs glucose, insulin, lipids, gonadotropins, sex steroids, SHBG Gonad and sex steroids, in urine Salivary insulin No Hyperinsulinemia in PCOS children until the later. Other reproductive abnormalities may also develop later. Sons of PCOS women exhibit higher body weight from early infancy. Insulin resistance became evident as they got older, risk factor for later onset of type 2 diabetes and cardiovascular disease. Some metabolic features of PCOS present in daughters with PCOS. Adiponectin might be an early marker. PCOS daughters have hyperinsulinemia and an increased ovarian volume before the onset of puberty and persist during pubertal development. Biochemical abnormalities of PCOS appear during late puberty. No difference

18 Compromised children outcomes

19 2012 Pregnancy Conclusions (agreement) Women with PCOS may be at increased risk for adverse pregnancy outcomes, this may be exacerbated by obesity and/or IR Health should be optimized before conception (lifestyle, diet, smoking, etc) Miscarriage rates are not increased in PCOS Pregnancy should be observed closely (GDM, hypertension) Pregnancy associated risk are greater in PCOS diagnosed by NIH criteria Babies born may have increased morbidity and mortality No evidence for decreased pregnancy complications with use of metformin before conception/during pregnancy Level of evidence B B A B B B A

20 2012 Pregnancy - Knowledge gaps Any value of periconceptional diets? Should there be increased antenatal monitoring, including earlier screening for GDM, additional Doppler studies? Long-term outcome of children born from PCOS? Long-term outcome women with PCOS who develop GDM or gestational hypertension compared to women who do not conceive

21 Take Home Messages Personal considerations PCOS is heterogeneous by definition Overall infertility prognosis in PCOS is very good Compromised pregnancy / children outcomes Influence nature vs nurture on child health uncertain Need intervention studies with proper follow-up / end-points

22 Reproductive Research Group PhD students, and collaborators Rotterdam ( ) Pache, Schoot, vsantbrink, Schipper, Imani, de Jong, vheusden Eijkemans, Mulders, Hohmann, Heijnen, Baart, de Klerk, vdgaast Blok, Laven, Macklon Utrecht (2004-) Verberg, Knauff, vdisseldorp Janse, Voorhuis, Kasius, Verhulst, Broer, Hamdin, Sterrenburg, de Wilde, Daan Broekmans, Heijnen, Eijkemans Main international collaborations; Devroey (Brussels), Bouchard (Paris), Tarlatzis (Greece), Hsueh (stanford)

Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?

Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index? Chettinad Health City Medical Journal Original Article Puvithra T*, Radha Pandiyan**, Pandiyan N*** *Assistant Professor, **Senior Consultant & Associate Professor, ***Prof & HOD, Department of Andrology

More information

Problems in PCOS pregnancy

Problems in PCOS pregnancy Problems in PCOS pregnancy Miscarriage Admission to NICU Cesarean Section Preeclampsia Mother Prematurity Preterm labour PIH Perinatal mortality Gestational Diabetes Problems with PCOS Pregnancy Problems

More information

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of

More information

Pregnancy outcome in women with polycystic ovary syndrome

Pregnancy outcome in women with polycystic ovary syndrome International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nivedhitha VS et al. Int J Reprod Contracept Obstet Gynecol. 2015 Aug;4(4):1169-1175 www.ijrcog.org pissn 2320-1770 eissn

More information

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University

More information

Rotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause?

Rotterdam Criteria 9/30/2017. A Changing Paradigm in PCOS. Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause? Disclosure Polycystic Ovary Syndrome - Is the Cardiometabolic Risk Increased After Menopause? Fractyl laboratories, Inc Anuja Dokras, MD., Ph.D. Professor of Obstetrics and Gynecology Director PENN PCOS

More information

RISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS)

RISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS) RISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS) N. A. Bagegni, BS 1, J Blaine, BS 1, B J VanVoorhis, MD 1, A Dokras, MD.PhD 2

More information

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji

More information

Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome

Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome Endocrine Journal 2015, 62 (11), 1017-1023 Original Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome Mari Sawada, Hisashi Masuyama, Kei Hayata, Yasuhiko Kamada, Keiichiro

More information

Endothelial function is impaired in women who had pre-eclampsia

Endothelial function is impaired in women who had pre-eclampsia Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United

More information

Timing and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood

Timing and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood Note: for non-commercial purposes only Timing and tempo of first year growth in relation to cardiovascular and metabolic risk profile in early adulthood Anita Hokken-Koelega Professor of Pediatric Endocrinology

More information

The Impact of Insulin Resistance on Long-Term Health in PCOS

The Impact of Insulin Resistance on Long-Term Health in PCOS Saturday, April 16 th, 2016 PCOS Challenge & Thomas Jefferson University PCOS Awareness Symposium Philadelphia The Impact of Insulin Resistance on Long-Term Health in PCOS Katherine Sherif, MD Professor

More information

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women

More information

Thoughts on PCOS Female Androgenization Syndrome FAS

Thoughts on PCOS Female Androgenization Syndrome FAS Thoughts on PCOS Female Androgenization Syndrome FAS Stan Korenman, M.D. Distinguished Professor of Medicine-Endocrinology and Associate Dean - Ethics David Geffen School of Medicine at UCLA Conflicts

More information

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Screening and Diagnosis of Diabetes Mellitus in Taiwan Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

PCOS & Diet Therapy. Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015

PCOS & Diet Therapy. Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015 PCOS & Diet Therapy Dr. Ladan Giahi Immunonutritionist Avicenna Research Institute October 2015 Questions to be discussed: 1) Why dietary modification is considered as first line of treatment? 2) What

More information

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa

More information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte

More information

CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME

CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME Enrico Carmina Executive Director & CEO of Androgen Excess & PCOS Society Professor of Endocrinology Department of Health Sciences and Mother and Child

More information

Obstetric complications and management in women with polycystic ovary syndrome

Obstetric complications and management in women with polycystic ovary syndrome Obstetric complications and management in women with polycystic ovary syndrome M Tamer MUNGAN, MD., Prof Obstetrics and Gynecologıst -Perinalogy tdmungan@gmail.com F E R T I L I T Y SUBFERTILİTY INFERTILITY

More information

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014 Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome

More information

International Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-2, Issue-11, November- 2016]

International Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-2, Issue-11, November- 2016] Maternal polycystic ovary syndrome (PCOS) and Antenatal (ANC) Complications: A Case Control Study Dr. Maincy Devadiya 1, Dr. Anubhav Jain 2, Dr. Sushma P. Sinha 3, Dr. Anita G. Kaul 4 and Dr. Suman Meena

More information

Reproductive outcome in women with body weight disturbances

Reproductive outcome in women with body weight disturbances Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight

More information

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about

More information

IS PCOS ASSOCIATED WITH A HIGHER PREGNANCY LOSS? NO BY DR SHEELA V.MANE

IS PCOS ASSOCIATED WITH A HIGHER PREGNANCY LOSS? NO BY DR SHEELA V.MANE IS PCOS ASSOCIATED WITH A HIGHER PREGNANCY LOSS? NO BY DR SHEELA V.MANE CURRICULUM VITAE Name Qualifications : Prof. Sheela V. Mane : MBBS, M.D, FICOG, FICMCH Contribution to FOGSI: Chairperson Safe Motherhood

More information

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland Professor Paul Hofman Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland 9:25-9:50 Endocrine and Metabolic Consequences of Being Born Preterm

More information

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University CREATING A PCOS TREATMENT PLAN Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University PCOS: CREATING A TREATMENT PLAN Good treatment plans are based on sound and complete evaluations History of

More information

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D., a Bart C. J. M. Fauser, M.D., Ph.D., b Joop S. E. Laven,

More information

Psychological impact of Polycystic Ovary Syndrome (PCOS)

Psychological impact of Polycystic Ovary Syndrome (PCOS) Psychological impact of Polycystic Ovary Syndrome (PCOS) Dr Mandy Deeks PhD Psychologist Former Deputy CEO & Head of Translation, Education & Communication Unit Today: 5 things to ponder 1. PCOS is complex

More information

Pregnancy complications in women with polycystic ovary syndrome

Pregnancy complications in women with polycystic ovary syndrome Human Reproduction Update, Vol.21, No.5 pp. 575 592, 2015 Advanced Access publication on June 27, 2015 doi:10.1093/humupd/dmv029 Pregnancy complications in women with polycystic ovary syndrome Stefano

More information

Pregnancy outcomes in Korean women with diabetes

Pregnancy outcomes in Korean women with diabetes Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict

More information

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest. Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives

More information

Gestational Diabetes. Gestational Diabetes:

Gestational Diabetes. Gestational Diabetes: Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,

More information

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Amy Loden, MD, FACP, NCMP Disclosures Research: None Financial: none applicable to this presentation PRIUM QEssentials Market Research

More information

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Polycystic Ovary Disease: A Common Endocrine Disorder in Women Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University

More information

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

S. AMH in PCOS Research Insights beyond a Diagnostic Marker S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.

More information

Metabolic changes in menopausal transition

Metabolic changes in menopausal transition Metabolic changes in menopausal transition Terhi T. Piltonen M.D., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO

More information

Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)

Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD) Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD) Pr Sophie Christin-Maitre Reproductive Endocrine Unit, Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie INSERM U933 Paris, France

More information

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic

More information

2018 Standard of Medical Care Diabetes and Pregnancy

2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests

More information

Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI

Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Narbeh Melikian*, Ajay M Shah*, Martyn R Thomas, Roy Sherwood, Mark T

More information

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and

More information

The optimal nutritional balance needed for preventing metabolic syndrome while achieving optimal development for preterm infants

The optimal nutritional balance needed for preventing metabolic syndrome while achieving optimal development for preterm infants Pediatric Endocrinology In Premature Infants The optimal nutritional balance needed for preventing metabolic syndrome while achieving optimal development for preterm infants Dr. Iris Morag Prof. Orit Hamiel

More information

METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY

METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA

Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA What have we learned from Multi-Clinical Trials in PCOS: Focus on Infertility Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Disclosures Consultant: Euroscreen,

More information

Polycystic ovary syndrome in young women - new ideas

Polycystic ovary syndrome in young women - new ideas Polycystic ovary syndrome in young women - new ideas Disclosures Minor shareholder IVF clinic Grant support MSD, Merck and Ferring Grant support NHMRC Perspective is everything in PCOS Peacock s 2013 Polycystic

More information

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse

More information

Update on PCOS Research. Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA

Update on PCOS Research. Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Update on PCOS Research Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Conflicts Consultant: Euroscreen, AstraZeneca, Ferring, Clarus, Kindex, Takeda Funding:

More information

Vitamin D supplementation of professionally active adults

Vitamin D supplementation of professionally active adults Vitamin D supplementation of professionally active adults VITAMIN D MINIMUM, MAXIMUM, OPTIMUM FRIDAY, SEPTEMBER 22 ND 2017 Samantha Kimball, PhD, MLT Research Director Pure North S Energy Foundation The

More information

3. Metformin therapy for PCOS

3. Metformin therapy for PCOS 1. Introduction The key clinical features of polycystic ovary syndrome (PCOS) are hyperandrogenism (hirsutism, acne, alopecia) and menstrual irregularity with associated anovulatory infertility. 1 The

More information

Vishwanath Pattan Endocrinology Wyoming Medical Center

Vishwanath Pattan Endocrinology Wyoming Medical Center Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected

More information

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,

More information

On the path to less intrusive IVF

On the path to less intrusive IVF 23rd Annual Meeting of the European Society of Human Reproduction and Embryology Lyon, France July 1 4, 2007 Organon Sponsored Symposium Monday, July 2, 2007, 11.45 AM 1.00 PM L Amphithéâtre, Palais des

More information

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Life-long condition Hirsutism Menstrual irregularities? Pronounced

More information

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)

More information

Clinical Study Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome

Clinical Study Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 182582, 6 pages http://dx.doi.org/10.1155/2013/182582 Clinical Study Risks for Gestational Diabetes Mellitus and Pregnancy-Induced

More information

Epidemiology and Prevention

Epidemiology and Prevention Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and

More information

Dr.Shobha N Gudi. Prof. and HOD. Dept of OBG. St. Philomenas Hospital, Dr Malathi Manipal hospital, Excel Care, Sagar Chandramma Hospitals, Bangalore.

Dr.Shobha N Gudi. Prof. and HOD. Dept of OBG. St. Philomenas Hospital, Dr Malathi Manipal hospital, Excel Care, Sagar Chandramma Hospitals, Bangalore. Dr.Shobha N Gudi MD, DNB, FICOG, CIMP Prof. and HOD. Dept of OBG. St. Philomenas Hospital, Dr Malathi Manipal hospital, Excel Care, Sagar Chandramma Hospitals, Bangalore. President elect BSOG (Bengaluru

More information

Diabetic Medicine. Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data.

Diabetic Medicine. Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data. Myo-inositol may prevent gestational diabetes in PCOS women. Preliminary data. Journal: Diabetic Medicine Manuscript ID: DME--00 Manuscript Type: Short Report Date Submitted by the Author: -May- Complete

More information

AEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y. V o l u m e 2, I s s u e 12 D E C E M B E R 3 1,

AEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y. V o l u m e 2, I s s u e 12 D E C E M B E R 3 1, AEPCOS NewSLET TER A N D R O G E N E X C E S S & P C O S S O C I E T Y D E C E M B E R 2 0 1 4 n e w s l e t t e r S M O K I N G I N W O M E N W I T H P C O S This issue newsletter reports the final program

More information

Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes

Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes Stefano Palomba, M.D., a Angela Falbo, M.D., a Tiziana Russo, M.D.,

More information

Polycystic Ovary Syndrome (PCOS):

Polycystic Ovary Syndrome (PCOS): Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,

More information

Metabolomic profiles of childhood obesity

Metabolomic profiles of childhood obesity Note: for non-commercial purposes only Metabolomic profiles of childhood obesity Wei Perng, Matthew W. Gillman, Abby F. Fleisch, Ryan D. Michalek, Steven Watkins, Elvira Isganaitis, Mary-Elizabeth Patti,

More information

Proven and Proposed Cardiovascular Benefits of Soyfoods

Proven and Proposed Cardiovascular Benefits of Soyfoods Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study

Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study Keystone, Colorado, July 2013 Practical Ways to Achieve Targets in Diabetes Care Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study Professor David Dunger Department

More information

On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome an epi-analysis

On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome an epi-analysis A C TA Obstetricia et Gynecologica AOGS SHORT RESEARCH REPORT On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome an epi-analysis ESZTER VANKY 1,2, FRANCIS

More information

Counseling and Long-term Follow up After Gestational Disorders

Counseling and Long-term Follow up After Gestational Disorders Counseling and Long-term Follow up After Gestational Disorders Tanya Melnik, MD Assistant Professor, University of Minnesota Sarina Martini, MD Ob/Gyn Resident, PGY4 University of Minnesota Counseling

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

Complications of Pregnancy and Lifetime Risk to Health. Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015

Complications of Pregnancy and Lifetime Risk to Health. Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015 Complications of Pregnancy and Lifetime Risk to Health Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015 Pregnancy as a window to future health In 2005 the CDC stated that almost

More information

Why Screen at 23? What can YOU do?

Why Screen at 23? What can YOU do? Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes

More information

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the

More information

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016 Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)

More information

Obesity and Fertility in Women: Can we and should we treat obesity prior to conception?

Obesity and Fertility in Women: Can we and should we treat obesity prior to conception? Obesity and Fertility in Women: Can we and should we treat obesity prior to conception? Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Obesity and Fertility in

More information

Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR.

Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR. Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR. Harri Niinikoski MD, PhD, Pediatric endocrinologist Professor of Nutrition in Medicine University of Turku/Physiology

More information

Overview. In Vitro Fertilization: a Success Story

Overview. In Vitro Fertilization: a Success Story Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco

More information

Introduction. Original Article

Introduction. Original Article Original Article Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort Reproductive Sciences

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Does (rapid) early weight gain cause adult disease and obesity? Ines M. Anchondo DrPH, RD, CSP

Does (rapid) early weight gain cause adult disease and obesity? Ines M. Anchondo DrPH, RD, CSP Does (rapid) early weight gain cause adult disease and obesity? Ines M. Anchondo DrPH, RD, CSP Annotated Reference List Adair, L. S., et al. (2009). "Size at birth, weight gain in infancy and childhood,

More information

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona Lessons from conducting research in an American Indian community: The Pima Indians of Arizona Peter H. Bennett, M.B., F.R.C.P. Scientist Emeritus National Institute of Diabetes and Digestive and Kidney

More information

New PCOS guidelines: What s relevant to general practice

New PCOS guidelines: What s relevant to general practice New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris

More information

CARDIOVASCULAR RISK FACTORS. Harpal S Randeva. Warwick Medical School University of Warwick, UK

CARDIOVASCULAR RISK FACTORS. Harpal S Randeva. Warwick Medical School University of Warwick, UK NORDIC FEDERATION OF SOCIETIES OF OBSTETRICS AND GYNAECOLOGY November, 2010 POLYCYSTIC OVARY SYNDROME THROUGH LIFE CARDIOVASCULAR RISK FACTORS Harpal S Randeva Warwick Medical School University of Warwick,

More information

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS PCOS Awareness Symposium Atlanta September 24 th, 2016 Preventing Diabetes & Cardiovascular Disease in PCOS Katherine Sherif, MD Professor & Vice Chair, Department of Medicine Director, Jefferson Women

More information

Management of Pregestational and Gestational Diabetes Mellitus

Management of Pregestational and Gestational Diabetes Mellitus Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is

More information

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy Objectives Diabetes and Obesity in Pregnancy. Health Impact for the mother and child Bresta Miranda, MD Assistant Professor of Clinical Medicine University of Miami, Miller School of Medicine Review physiologic

More information

Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study

Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2011;38(2):103-108 Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome:

More information

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011 Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled

More information

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this... PCOS What is PCOS? You'll be amazed when you read this... What is PCOS?. Who is at risk? How to get tested? What are the complications. Is there a cure? What are the right ways to eat? What lifestyle changes

More information

Supplemental Table 1. Study design and participant characteristics.

Supplemental Table 1. Study design and participant characteristics. Supplemental Table 1. Study design and participant characteristics. Study ID Study Design; Total No. of Participants Mean age at Parity Participant Selection Criteria Country; Year (PE/no PE) Index Pregnancy

More information

10/29/2011. Metabolic, Obstetric, and Gynecological Consequences of Bariatric Surgery. Case Presentation: Rachelle. Jonathan Carter, MD

10/29/2011. Metabolic, Obstetric, and Gynecological Consequences of Bariatric Surgery. Case Presentation: Rachelle. Jonathan Carter, MD Metabolic, Obstetric, and Gynecological Consequences of Bariatric Surgery 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression

More information

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.

More information

The Ever-Changing Approaches to Diabetes in Pregnancy

The Ever-Changing Approaches to Diabetes in Pregnancy The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches

More information

Socioeconomic inequalities in lipid and glucose metabolism in early childhood

Socioeconomic inequalities in lipid and glucose metabolism in early childhood 10 Socioeconomic inequalities in lipid and glucose metabolism in early childhood Gerrit van den Berg, Manon van Eijsden, Francisca Galindo-Garre, Tanja G.M. Vrijkotte, Reinoud J.B.J. Gemke BMC Public Health

More information

Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies

Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies 2017 Illinois-AACE 2017 Annual Meeting October 14, 2017 Learning Objectives 1) Understand the challenges

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND 7% of all women 18-45 Obesity 1/3 of all US women Incidence of PCOS is increasing with increase obesity Obesity Irregular

More information